Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

SIMM describes bile acid receptor antagonists

April 5, 2019

Mkrn3 gene overexpression in mice generates model of delayed puberty

April 5, 2019

FDA clears IND application for phase I/II study of HMI-102 gene therapy candidate

April 5, 2019

Development of new long-term animal model of Graves' disease verified

April 4, 2019

Dermelix partners with EspeRare on DMX-101 for X-linked hypohidrotic ectodermal dysplasia

April 3, 2019

Auris announces randomization of first dose cohort in phase Ib study of AM-201

April 1, 2019

Rhythm Pharmaceuticals provides update on setmelanotide development program

April 1, 2019

Orchard Therapeutics presents new registrational data for OTL-200 in MLD

March 29, 2019

Pannexin 1 channelopathy causes human oocyte death

March 29, 2019

Novel small-molecule RXFP3/4 agonist increases food intake in vivo

March 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...